Cargando…

Unique Genomic Landscape of High-Grade Neuroendocrine Cervical Carcinoma: Implications for Rethinking Current Treatment Paradigms

PURPOSE: High-grade neuroendocrine cervical cancer (HGNECC) is an uncommon malignancy with limited therapeutic options; treatment is patterned after the histologically similar small-cell lung cancer (SCLC). To better understand HGNECC biology, we report its genomic landscape. PATIENTS AND METHODS: N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eskander, Ramez N., Elvin, Julia, Gay, Laurie, Ross, Jeffrey S., Miller, Vincent A., Kurzrock, Razelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2020
Materias:	Original Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529537/ https://www.ncbi.nlm.nih.gov/pubmed/33015532 http://dx.doi.org/10.1200/PO.19.00248

Ejemplares similares

KRAS‐Mutated, Estrogen Receptor‐Positive Low‐Grade Serous Ovarian Cancer: Unraveling an Exceptional Response Mystery
por: Kato, Shumei, et al.
Publicado: (2021)

Molecular landscape of pancreatic cancer: implications for current clinical trials
por: Heestand, Gregory M., et al.
Publicado: (2015)

Immunotherapy in endometrial cancer - an evolving therapeutic paradigm
por: Longoria, Teresa C., et al.
Publicado: (2015)

Rethinking the Current “Stage-and-Wait” Paradigm
por: Ragoler, Morel, et al.
Publicado: (2023)

Erratum to: Immunotherapy in endometrial cancer - an evolving therapeutic paradigm
por: Longoria, Teresa C., et al.
Publicado: (2016)

Unique molecular signatures as a hallmark of patients with metastatic breast cancer: Implications for current treatment paradigms
por: Wheler, Jennifer J., et al.
Publicado: (2014)

Rethinking the Antibiotic Discovery Paradigm
por: Hancock, Robert E.W.
Publicado: (2015)

Genomic analyses of high‐grade neuroendocrine gynecological malignancies reveal a unique mutational landscape and therapeutic vulnerabilities
por: Mahdi, Haider, et al.
Publicado: (2021)

Beyond angiogenesis blockade: targeted therapy for advanced cervical cancer
por: Eskander, Ramez N., et al.
Publicado: (2014)

Evolution of the Targeted Therapy Landscape for Cholangiocarcinoma: Is Cholangiocarcinoma the ‘NSCLC’ of GI Oncology?
por: Gupta, Amol, et al.
Publicado: (2023)

Analysis of MDM2 Amplification: Next-Generation Sequencing of Patients With Diverse Malignancies
por: Kato, Shumei, et al.
Publicado: (2018)

Metastatic small cell neuroendocrine carcinoma of the cervix treated with the PD-1 inhibitor, nivolumab: a case report
por: Paraghamian, Sarah E., et al.
Publicado: (2017)

Cancer immunity marker RNA expression levels across gynecologic cancers: Implications for immunotherapy
por: Jou, Jessica, et al.
Publicado: (2023)

Is It Time to Rethink Our Weight Loss Paradigms?
por: Gentil, Paulo, et al.
Publicado: (2020)

Disseminated Endometriosis and Low-Grade Endometrioid Stromal Sarcoma in a Patient with a History of Uterine Morcellation for Adenomyosis
por: Stefanko, Daniel P., et al.
Publicado: (2020)

Rethinking treatment paradigms for the deployment of SARS-CoV-2 antiviral drugs on the shifting landscape of new variants
por: Hentzien, Maxime, et al.
Publicado: (2022)

Biomarker Landscape in Neuroendocrine Tumors With High-Grade Features: Current Knowledge and Future Perspective
por: Prisciandaro, Michele, et al.
Publicado: (2022)

Rethinking paradigms for studying mechanisms of action of plant bioactives
por: Kay, C D
Publicado: (2015)

Rethinking antimicrobial stewardship paradigms in the context of the gut microbiome
por: Shahi, Farah, et al.
Publicado: (2019)

Full Lockdowns Against the Pandemic: Time to Rethink the Paradigm
por: Wilches Visbal, Jorge H., et al.
Publicado: (2023)

Time to Rethink the Current Paradigm for Assessing Kidney Function in Drug Development and Beyond
por: Sharma, Ashish, et al.
Publicado: (2021)

Primary low-grade endometrial stromal sarcoma of the omentum
por: Clair, Kiran, et al.
Publicado: (2017)

Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients
por: Charo, Lindsey M., et al.
Publicado: (2020)

Dramatic response to Laetrile and cannabidiol (CBD) oil in a patient with metastatic low grade serous ovarian carcinoma
por: Barrie, Allison M., et al.
Publicado: (2019)

Comprehensive Landscape of Cyclin Pathway Gene Alterations and Co-occurrence with FGF/FGFR Aberrations Across Urinary Tract Tumors
por: Jardim, Denis L F, et al.
Publicado: (2022)

Landscape of Cyclin Pathway Genomic Alterations Across 5,356 Prostate Cancers: Implications for Targeted Therapeutics
por: Jardim, Denis L., et al.
Publicado: (2021)

Genomic landscape of advanced basal cell carcinoma: Implications for precision treatment with targeted and immune therapies
por: Goodman, Aaron M., et al.
Publicado: (2017)

Genomic landscape of salivary gland tumors
por: Kato, Shumei, et al.
Publicado: (2015)

Rethinking the respiratory paradigm of COVID-19: a ‘hole’ in the argument
por: Rajendram, Rajkumar, et al.
Publicado: (2020)

Liquid biopsy: current technology and clinical applications
por: Nikanjam, Mina, et al.
Publicado: (2022)

PD-L1 gene amplification and focality: relationship with protein expression
por: Jardim, Denis Leonardo, et al.
Publicado: (2023)

Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores Cancer Center
por: Sharabi, Andrew, et al.
Publicado: (2017)

A Niche for Infectious Disease in Environmental Health: Rethinking the Toxicological Paradigm
por: Feingold, Beth J., et al.
Publicado: (2010)

Rethinking the early intubation paradigm of COVID-19: time to change gears?
por: Rola, Philippe, et al.
Publicado: (2020)

Pandemic treaty needs to start with rethinking the paradigm of global health security
por: Fukuda-Parr, Sakiko, et al.
Publicado: (2021)

Expression of TIM3/VISTA checkpoints and the CD68 macrophage-associated marker correlates with anti-PD1/PDL1 resistance: implications of immunogram heterogeneity
por: Kato, Shumei, et al.
Publicado: (2020)

Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapy
por: Louie, Bryan H., et al.
Publicado: (2022)

Immunotherapy as a treatment strategy in advanced stage and recurrent endometrial cancer: review of current phase III immunotherapy clinical trials
por: Eskander, Ramez N., et al.
Publicado: (2021)

Rethinking surgical concepts for early cervical cancer
por: Seol, Hyun-Joo, et al.
Publicado: (2018)

Rethinking balance and impartiality in journalism? How the BBC attempted and failed to change the paradigm
por: Wahl-Jorgensen, Karin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2mljp2vlav70j4nab4tl620t52